Determination of transport in the Caco-2 cell assay of compounds varying in lipophilicity using LC-MS: enhanced transport of Leu-enkephalin analogues

被引:20
作者
Wong, AK
Ross, BP
Chan, YN
Artursson, P
Lazorova, L
Jones, A
Toth, I [1 ]
机构
[1] Univ Queensland, Sch Pharm, St Lucia, Qld 4072, Australia
[2] Uppsala Univ, Dept Pharm, SE-75123 Uppsala, Sweden
[3] Univ Queensland, Ctr Drug Design & Dev, St Lucia, Qld 4072, Australia
基金
英国惠康基金;
关键词
Caco-2; LC-MS; Leu-enkephalin; lipoamino acid; sugar conjugation;
D O I
10.1016/S0928-0987(02)00078-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: To synthesize a number of analogues of Leu-enkephalin with different lipophilicities and to develop an LC-MS method for determining the Caco-2 cell permeability values of these compounds. Methods: A number of sugar and sugar plus lipoamino acid analogues of Leu-enkephalin were synthesized by solid-phase and solution methods. An LC-MS method was developed for analyzing the Caco-2 cell assay samples and validated against the traditional method using radiolabelled compounds. Results: A sensitive and specific LC-MS assay was developed. Standard curves were linear in the range of 0.025-5 muM. Apparent permeability values determined by LC-MS and liquid scintillation counter were identical, for both a hydrophilic drug, cephalexin and a lipophilic Leu-enkaphalin analogue. Caco-2 permeability values for the analogues of Leu-enkephalin were determined and it was found that attachment of sugar or sugar and lipoamino acid to the Leu-enkephalin peptide resulted in an increase in the apparent permeability values compared to the native peptide, which was not transported across the Caco-2 cell monolayers. Conclusions: A rapid, generic LC-MS method for analyzing a range of compounds was developed. Attachment of a sugar or sugar and lipoamino acid to Leu-enkephalin improves the apparent permeability across Caco-2 cell monolayers. (C) 2002 Published by Elsevier Science B.V.
引用
收藏
页码:113 / 118
页数:6
相关论文
共 19 条
[1]   CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ARTURSSON, P ;
KARLSSON, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) :880-885
[2]   SYSTEMIC DELIVERY OF THERAPEUTIC PEPTIDES AND PROTEINS [J].
BANGA, AK ;
CHIEN, YW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 48 (1-3) :15-50
[3]  
Caldwell GW, 1998, J MASS SPECTROM, V33, P607, DOI 10.1002/(SICI)1096-9888(199807)33:7<607::AID-JMS672>3.0.CO
[4]  
2-O
[5]  
COHEN ML, 1983, J PHARMACOL EXP THER, V224, P379
[6]   Solid phase synthesis of C-terminal carbohydrate modified enkephalins [J].
Drouillat, B ;
Kellam, B ;
Dekany, G ;
Starr, MS ;
Toth, I .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (17) :2247-2250
[7]  
GEARY LE, 1982, J PHARMACOL EXP THER, V221, P104
[8]  
GIBBONS WA, 1990, LIPIDIC PEPTIDES, V1, P1175
[9]   Synthesis and in vitro evaluation of lipoamino acid and carbohydrate-modified enkephalins as potential antinociceptive agents [J].
Kellam, B ;
Drouillat, B ;
Dekany, G ;
Starr, MS ;
Toth, I .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 161 (01) :55-64
[10]  
Lee V.H.L., 1990, ADV DRUG DELIV REV, V4, P171